Trial · NCT00153101
Results by group97
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 97
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| ONTARGET. Composite Endpoint of Cardiovascular Death, Non-fatal Myocardial Infarction, Non-fatal Stroke and Hospitalization for Congestive Heart Failure | Telmisartan/Ramipril (ONTARGET) | 1386 | participants | ||
| ONTARGET. Composite Endpoint of Cardiovascular Death, Non-fatal Myocardial Infarction, Non-fatal Stroke and Hospitalization for Congestive Heart Failure | Telmisartan (ONTARGET) | 1423 | participants | ||
| ONTARGET. Composite Endpoint of Cardiovascular Death, Non-fatal Myocardial Infarction, Non-fatal Stroke and Hospitalization for Congestive Heart Failure | Ramipril (ONTARGET) | 1412 | participants | ||
| ONTARGET. Composite Endpoint of Cardiovascular Death, Non-fatal Myocardial Infarction and Non-fatal Stroke | Telmisartan/Ramipril (ONTARGET) | 1200 | participants | ||
| ONTARGET. Composite Endpoint of Cardiovascular Death, Non-fatal Myocardial Infarction and Non-fatal Stroke | Telmisartan (ONTARGET) | 1190 | participants | ||
| ONTARGET. Composite Endpoint of Cardiovascular Death, Non-fatal Myocardial Infarction and Non-fatal Stroke | Ramipril (ONTARGET) | 1210 | participants | ||
| ONTARGET. Cardiovascular Death | Telmisartan/Ramipril (ONTARGET) | 620 | participants | ||
| ONTARGET. Cardiovascular Death | Telmisartan (ONTARGET) | 598 | participants | ||
| ONTARGET. Cardiovascular Death | Ramipril (ONTARGET) | 603 | participants | ||
| ONTARGET. Non-fatal Myocardial Infarction | Telmisartan/Ramipril (ONTARGET) | 424 | participants | ||
| ONTARGET. Non-fatal Myocardial Infarction | Telmisartan (ONTARGET) | 431 | participants | ||
| ONTARGET. Non-fatal Myocardial Infarction | Ramipril (ONTARGET) | 400 | participants | ||
| ONTARGET. Non-fatal Stroke | Telmisartan/Ramipril (ONTARGET) | 364 | participants | ||
| ONTARGET. Non-fatal Stroke | Telmisartan (ONTARGET) | 364 | participants | ||
| ONTARGET. Non-fatal Stroke | Ramipril (ONTARGET) | 402 | participants | ||
| ONTARGET. Hospitalization for Congestive Heart Failure | Telmisartan/Ramipril (ONTARGET) | 332 | participants | ||
| ONTARGET. Hospitalization for Congestive Heart Failure | Telmisartan (ONTARGET) | 394 | participants | ||
| ONTARGET. Hospitalization for Congestive Heart Failure | Ramipril (ONTARGET) | 354 | participants | ||
| ONTARGET. Doubling of Serum Creatinine in Diabetic Nephropathy Patients | Telmisartan/Ramipril (ONTARGET) | 30 | participants | ||
| ONTARGET. Doubling of Serum Creatinine in Diabetic Nephropathy Patients | Telmisartan (ONTARGET) | 24 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00153101/results